Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Interim Management Statement

29 Jan 2008 09:00

Standard Life Euro Pri Eqty Tst PLC29 January 2008 Standard Life European Private Equity Trust PLC Interim management statement for the quarter ended 31 December 2007 Standard Life European Private Equity Trust PLC ("the Company") presents itsinterim management statement for the period from 1 October 2007 to 31 December2007. This announcement constitutes the Company's first interim managementstatement for the year ending 30 September 2008 in accordance with rule 4.3 ofthe UK Listing Authority's Disclosure and Transparency Rules. This interimstatement summarises information as at 31 December 2007 and any materialdevelopments up to 28 January 2008. Investment objective To achieve long-term capital gains through investment in a diversified portfolioof private equity funds investing predominantly in Europe. Benchmark The Company has no defined benchmark. Performance The Company's audited net asset value per ordinary share ("NAV") was 241.3p asat 30 September 2007 (diluted - 237.7p). The Company's NAV as at 31 December2007 will be announced on or around 18 March 2008. The share price of theCompany's ordinary shares was 217.5p as at 31 December 2007, compared to 226.5pas at 30 September 2007, a decline of 4.0% over the quarter. Over the sameperiod the MSCI Europe Index (sterling adjusted) rose 1.5% and the FTSE AllShare Index fell 0.9%. Financial position During the quarter ended 31 December 2007 the Company received distributionsfrom its private equity fund interests of Β£21.2 million (quarter ended 30September 2007 - Β£38.1 million) and funded Β£43.0 million of draw downs (quarterended 30 September 2007 - Β£44.7 million). The Company had aggregate outstandingcommitments to its private equity fund interests of Β£338.8 million as at 31December 2007 (30 September 2007 - Β£366.0 million). As at 31 December 2007 the Company held aggregate cash and money market balancesof Β£43.2 million (30 September 2007 - Β£64.2 million). As at 31 December 2007 theCompany's Β£60 million committed revolving credit facility was undrawn (30September 2007 - nil). Material events and transactions During the quarter the Company made no new private equity fund commitments. On 28 December 2007 the Company issued 100,000 ordinary shares, following theconversion of 100,000 Founder A shares by a member of the Company's manager, SLCapital Partners LLP. As at 31 December 2007 the Company's issued ordinary sharecapital was 159,922,567 ordinary shares of 0.2p each. On 28 January 2008 shareholders approved a final dividend for the year ended 30September 2007 of 3.5p per ordinary share at the Company's annual generalmeeting. This final dividend will be paid on 1 February 2008. For further information please contact:- Peter McKellar of SL Capital Partners LLP (0131 245 0055) Note:- Standard Life European Private Equity Trust PLC is an investment company managedby SL Capital Partners LLP, the ordinary shares of which are admitted to listingby the UK Listing Authority and to trading on the Stock Exchange and which seeksto conduct its affairs so as to qualify as an investment trust under Section 842of the Income and Corporation Taxes Act 1988. The Board of Standard LifeEuropean Private Equity Trust PLC is independent of Standard Life plc This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Apr 202212:06 pmRNSChange of Name
22nd Mar 20222:14 pmRNSResult of AGM
21st Mar 202211:26 amRNSDirector Declaration
14th Mar 20225:30 pmRNSFTSE Russell Indices
14th Mar 20227:00 amRNSEstimated NAV at 28 February 2022
9th Mar 20222:07 pmRNSFirst Interim Dividend
24th Feb 20227:00 amRNSEdison review on Standard Life Private Equity Trst
14th Feb 20227:00 amRNSEstimated NAV at 31 January 2022
4th Feb 20223:24 pmRNSAnnual Report
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
27th Jan 20227:05 amRNSEstimated NAV at 31 December 2021
27th Jan 20227:00 amRNSAnnual Financial Report
6th Jan 20229:04 amRNSQuarterly disclosure
15th Dec 20217:00 amRNSEstimated NAV as at 30 November 2021
14th Dec 20213:48 pmRNSFourth Interim Dividend
6th Dec 20217:00 amRNSEdison review on Standard Life Private Equity Trst
12th Nov 20217:00 amRNSEstimated NAV at 31 October 2021
2nd Nov 20214:25 pmRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSEstimated NAV at 30 September 2021
4th Oct 20214:15 pmRNSQuarterly disclosure
29th Sep 20217:02 amRNSEstimated NAV at 31 August 2021
29th Sep 20217:00 amRNSQuarterly Investment Update at 30 June 2021
17th Sep 20211:10 pmRNSUpdate research from QuotedData
7th Sep 20217:00 amRNSThird Interim Dividend
1st Sep 20217:00 amRNSDirectorate Change
16th Aug 202110:19 amRNSDirector/PDMR Shareholding
13th Aug 20217:00 amRNSEstimated NAV at 31 July 2021
10th Aug 20214:41 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
5th Aug 20213:32 pmRNSDirector/PDMR Shareholding
19th Jul 202111:58 amRNSEdison issues review on Standard Life Private
14th Jul 20219:05 amRNSDirector Declaration
14th Jul 20217:00 amRNSEstimated NAV at 30 June 2021
9th Jul 20213:29 pmRNSDoc re. Half yearly report
2nd Jul 20214:35 pmRNSQuarterly disclosure
29th Jun 20217:05 amRNSEstimated NAV at 31 May 2021
29th Jun 20217:00 amRNSHalf-year Report
14th Jun 20212:48 pmRNSSecond Interim Dividend
17th May 20217:00 amRNSEstimated NAV at 30 April 2021
12th May 20214:06 pmRNSDirector/PDMR Shareholding
27th Apr 202112:21 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:05 amRNSEstimated NAV at 31 March 2021
22nd Apr 20217:00 amRNSQuarterly Investment Update at 31 December 2020
9th Apr 202111:58 amRNSHolding(s) in Company
6th Apr 20214:11 pmRNSQuarterly disclosure
23rd Mar 20211:50 pmRNSResult of AGM
12th Mar 20217:00 amRNSEstimated NAV as at 28 February 2021
8th Mar 20217:00 amRNSFirst Interim Dividend
25th Feb 20217:00 amRNSEdison review on Standard Life Private Eqty Trust
12th Feb 202110:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.